KRSNAAHealthcare Service Provider
Krsnaa Diagnostics Ltd — Profit & Loss Statement
₹520.30
-4.64%
Krsnaa Diagnostics Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Reconciled Depreciation | 88.32 Cr | 74.55 Cr | 53.78 Cr | 41.39 Cr | — |
| Reconciled Cost Of Revenue | 229.94 Cr | 206.51 Cr | 155.39 Cr | 168.29 Cr | — |
| EBIT | 127.34 Cr | 86.50 Cr | 86.64 Cr | 103.37 Cr | — |
| Net Interest Income | -24.65 Cr | -16.49 Cr | 10.43 Cr | -3.58 Cr | — |
| Interest Expense | 24.65 Cr | 16.49 Cr | 6.43 Cr | 16.86 Cr | — |
| Normalized Income | 77.61 Cr | 56.84 Cr | 61.97 Cr | 68.58 Cr | — |
| Net Income From Continuing And Discontinued Operation | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| Total Expenses | 615.36 Cr | 549.93 Cr | 417.88 Cr | 365.11 Cr | — |
| Diluted Average Shares | 3.29 Cr | 3.28 Cr | 3.22 Cr | 2.99 Cr | — |
| Basic Average Shares | 3.23 Cr | 3.18 Cr | 3.14 Cr | 2.99 Cr | — |
| Diluted EPS | 23.56 | 17.31 | 19.29 | 22.88 | — |
| Basic EPS | 24.04 | 17.90 | 19.78 | 22.89 | — |
| Diluted NI Availto Com Stockholders | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| Net Income Common Stockholders | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Including Noncontrolling Interests | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| Net Income Continuous Operations | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| Tax Provision | 25.08 Cr | 13.17 Cr | 18.09 Cr | 18.12 Cr | — |
| Pretax Income | 102.69 Cr | 70.01 Cr | 80.20 Cr | 86.51 Cr | — |
| Other Non Operating Income Expenses | 25.54 Cr | 16.80 Cr | 0.36 Cr | 20000.00 | — |
| Net Non Operating Interest Income Expense | -24.65 Cr | -16.49 Cr | 10.43 Cr | -3.58 Cr | — |
| Interest Expense Non Operating | 24.65 Cr | 16.49 Cr | 6.43 Cr | 16.86 Cr | — |
| Operating Income | 101.80 Cr | 69.70 Cr | 69.24 Cr | 90.34 Cr | — |
| Operating Expense | 385.42 Cr | 343.43 Cr | 262.50 Cr | 196.82 Cr | — |
| Other Operating Expenses | 160.32 Cr | 157.41 Cr | 113.54 Cr | 84.29 Cr | — |
| Depreciation And Amortization In Income Statement | 88.32 Cr | 74.55 Cr | 53.78 Cr | 41.39 Cr | — |
| Depreciation Income Statement | 88.32 Cr | 74.55 Cr | 53.19 Cr | 41.03 Cr | — |
| Gross Profit | 487.22 Cr | 413.13 Cr | 331.74 Cr | 287.16 Cr | — |
| Cost Of Revenue | 229.94 Cr | 206.51 Cr | 155.39 Cr | 168.29 Cr | — |
| Total Revenue | 717.16 Cr | 619.63 Cr | 487.12 Cr | 455.45 Cr | — |
| Operating Revenue | 717.16 Cr | 619.63 Cr | 487.12 Cr | 455.45 Cr | — |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.04 Cr | -0.05 Cr | — |
| Tax Rate For Calcs | 0.24 | 0.19 | 0.23 | 0.21 | — |
| Normalized EBITDA | 215.66 Cr | 161.04 Cr | 140.24 Cr | 145.01 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 77.61 Cr | 56.84 Cr | 62.11 Cr | 68.39 Cr | — |
| EBITDA | 215.66 Cr | 161.04 Cr | 140.42 Cr | 144.76 Cr | — |
| Total Unusual Items | — | -0.05 Cr | 0.18 Cr | -0.25 Cr | 252.28 Cr |
| Total Unusual Items Excluding Goodwill | — | -0.05 Cr | 0.18 Cr | -0.25 Cr | 252.28 Cr |
| Interest Income | — | 16.76 Cr | 18.12 Cr | 14.91 Cr | 12.22 Cr |
| Rent Expense Supplemental | — | 8.97 Cr | 9.00 Cr | 8.43 Cr | 7.61 Cr |
| Special Income Charges | — | -0.05 Cr | 0.18 Cr | -0.25 Cr | -0.51 Cr |
| Other Special Charges | — | 0.05 Cr | -0.18 Cr | 0.25 Cr | 0.51 Cr |
| Total Other Finance Cost | — | 2.40 Cr | 1.26 Cr | 1.63 Cr | 1.01 Cr |
| Interest Income Non Operating | — | 16.76 Cr | 18.12 Cr | 14.91 Cr | 12.22 Cr |
| Amortization | — | 0.64 Cr | 0.59 Cr | 0.36 Cr | 1.36 Cr |
| Selling General And Administration | — | 13.01 Cr | 11.34 Cr | 8.25 Cr | 11.82 Cr |
| Selling And Marketing Expense | — | 2.94 Cr | 3.19 Cr | 1.81 Cr | 1.03 Cr |
| General And Administrative Expense | — | 10.07 Cr | 8.15 Cr | 6.44 Cr | 10.79 Cr |
| Rent And Landing Fees | — | 8.97 Cr | 9.00 Cr | 8.43 Cr | 7.61 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Krsnaa Diagnostics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.